Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis
Philippe Généreux(Morristown Medical Center), Marc R. Dweck(British Heart Foundation), Bernard Iung, Duk‐Hyun Kang(Ulsan College), Björn Redfors(Cardiovascular Research Foundation), Jozef Bartúnek(Onze Lieve Vrouwziekenhuis Hospital), Allan Schwartz(NewYork–Presbyterian Hospital), Gennaro Giustino(Cardiovascular Institute of the South), Roxanna Seyedin(Edwards Lifesciences (United States)), Bernard Prendergast, Brian R. Lindman(Washington University in St. Louis), David E. Newby(British Heart Foundation), Marko Banović(University of Belgrade), David J. Cohen(Saint Luke's Hospital), Martin B. Leon(NewYork–Presbyterian Hospital), Neil Craig(University of Edinburgh), Philippe Pîbarot(University of British Columbia)
Cited by 64
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases
|European Heart Journal|2014|4.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k